0002092364-25-000001.txt : 20251021 0002092364-25-000001.hdr.sgml : 20251021 20251021144655 ACCESSION NUMBER: 0002092364-25-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506(b) provides a "safer harbor" for a private offering FILED AS OF DATE: 20251021 DATE AS OF CHANGE: 20251021 EFFECTIVENESS DATE: 20251021 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Blue Marlin Therapeutics, Inc. CENTRAL INDEX KEY: 0002092364 ORGANIZATION NAME: EIN: 344759185 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-561543 FILM NUMBER: 251406611 BUSINESS ADDRESS: STREET 1: 200 GARRETT STREET STREET 2: SUITE S CITY: CHARLOTTESVILLE STATE: VA ZIP: 22902 BUSINESS PHONE: 434-980-8104 MAIL ADDRESS: STREET 1: 200 GARRETT STREET STREET 2: SUITE S CITY: CHARLOTTESVILLE STATE: VA ZIP: 22902 D 1 primary_doc.xml X0708 D LIVE 0002092364 Blue Marlin Therapeutics, Inc. 200 GARRETT STREET SUITE S CHARLOTTESVILLE VA VIRGINIA 22902 434-980-8104 DELAWARE None None Limited Liability Company true 2025 Sean Stalfort 200 Garrett Street Suite S Charlottesville VA VIRGINIA 22902 Executive Officer President and Secretary Paul Manning 200 Garrett Street Suite S Charlottesville VA VIRGINIA 22902 Executive Officer Chief Executive Officer Biotechnology Decline to Disclose 06b false 2025-10-06 true true false 1 NA None None None NA NA NA XX Unknown NA VA VIRGINIA false Indefinite 100000 Indefinite false 2 0 0 0 false Blue Marlin Therapeutics, Inc. Sean Stalfort Sean Stalfort President 2025-10-21